Skip to content

Changes

View changes from to


On October 1, 2024 at 3:27:47 PM UTC, Gravatar admin:
  • Updated description of VISE-KG from

    the dataset used in the following paper: VISE: Validated and Invalidated Symbolic Explanations for Knowledge Graph Integrity
    to
    VISE: Validated and Invalidated Symbolic Explanations for Knowledge Graph Integrity This collection includes all the data necessary to reproduce the results from the experimental evaluation of VISE at EXPLIMED @ ECAI'24. The data is an anonymized synthetic lung cancer benchmark that comprises clinical data extracted from heterogeneous sources such as publications, clinical trials, and clinical records representing patients diagnosed with lung cancer. We evaluate the VISE approach on three anonymized Lung Cancer KGs: LC-𝐾𝐺1, LC-𝐾𝐺2,and LC-𝐾𝐺3 The collection comprises nine data sets of three different sizes: - LC Knowledge Graph 1 (LC-KG1) models 29 lung cancer patients - LC Knowledge Graph 2 (LC-KG2) models 203 lung cancer patients - LC Knowledge Graph 3 (LC-KG3) models 319 lung cancer patients Three distinct KGs of different sizes are available, each with its own characteristics. - "Original KG": The original KG comprises of anonymized lung cancer patients with different medical characteristics. - "Enriched KG": Utilizes an inductive learnng technique of KG completion through self-supervised symbolic learning over the original KG. - "Transformed KG": Denotes a transformation of the KG depending on SHACL shapes evaluated across the enriched KGs. This procedure is used to determine the validity of the data. VISE is also evaluated with KGs comprising 1242 lung cancer patients (LungCancer-OriginalKG, LungCancer-EnrichedKG, and LungCancer-TransformedKG). Our experimental results demonstrate the effectiveness of this hybrid strategy, which combines the strengths of symbolic, numerical, and constraint validation paradigms. VISE implementation is publicly accessible on GitHub (https://github.com/SDM-TIB/VISE).



Before browse our site, please accept our cookies policy